Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mehy.2020.110127 http://scihub22266oqcxt.onion/10.1016/j.mehy.2020.110127 32759008!7372998!32759008     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Hypotheses 2020 ; 143 (ä): 110127 Nephropedia Template TP {{tp|p=32759008|t=2020. Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19 |pdf=|usr=}}{{32759008}} gab.com Text Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19 JO: Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32759008 #FOAvip Fenofibrate, which is a PPAR-alfpha agonist, increases the level of sulfatide. In this letter we hypothesize on the background of various findings that this is beneficial against COVID-19. Fenofibrate has been used for decades against hypercholesterolemia and has no serious side effects. Therefore, a trial giving fenofibrate to patients with corona virus infection is recommended. Twit Text FOAVip Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19 ????Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32759008 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32759008 #FOAvip English Wikipedia <ref>{{Cite pmid|32759008}}</ref> Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19 #MMPMID32759008 Buschard K Med Hypotheses 2020[Oct]; 143 (ä): 110127 PMID32759008show ga Fenofibrate, which is a PPAR-alfpha agonist, increases the level of sulfatide. In this letter we hypothesize on the background of various findings that this is beneficial against COVID-19. Fenofibrate has been used for decades against hypercholesterolemia and has no serious side effects. Therefore, a trial giving fenofibrate to patients with corona virus infection is recommended. |*Pandemics[MESH] |Adult[MESH] |Aging/blood[MESH] |Betacoronavirus/*physiology[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Child[MESH] |Coronavirus Infections/*drug therapy[MESH] |Drug Repositioning[MESH] |Fenofibrate/*pharmacology/therapeutic use[MESH] |Humans[MESH] |Hypercholesterolemia/blood/complications[MESH] |Hypertension/blood/complications[MESH] |Hypolipidemic Agents/*pharmacology/therapeutic use[MESH] |PPAR alpha/antagonists & inhibitors[MESH] |Pneumonia, Viral/*drug therapy[MESH] |SARS-CoV-2[MESH] |Sulfoglycosphingolipids/*blood[MESH]Fenofibrate increases the amount of sulfatide which seems beneficial a(epmc).pdf DeepDyve Pubget Overpricing